Lv33
260 积分 2021-09-06 加入
Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis of a randomised, open-label, phase 3 trial
1天前
已完结
Thrombopoietin-Receptor Agonists in Chemotherapy-Induced Thrombocytopenia
5天前
已完结
Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial
5天前
已完结
Ianalumab plus Eltrombopag in Immune Thrombocytopenia
5天前
已完结
A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia
5天前
已完结
Shengbai oral solution for chemotherapy-induced neutropenia and symptom management in non-small cell lung cancer: A multicenter, randomized, open-label trial
7天前
已完结
Thiotepa and Busulfan Combined With Cyclophosphamide Conditioning Regimen Plus Maintenance Therapy Improved the Disease-Free Survival of Patients With Relapsed/Refractory Hematologic Malignancies After Undergoing Allogeneic Transplantation
7天前
已完结
Tailoring Intensity: A Perspective on Thiotepa, Busulfan, and Fludarabine (TBF) Conditioning for Acute Leukemias and Myeloproliferative Neoplasms
7天前
已完结
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial
14天前
已完结
皖公网安备34019202002308
